193 related articles for article (PubMed ID: 12412675)
1. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
[TBL] [Abstract][Full Text] [Related]
2. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
4. Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.
Kanniess F; Richter K; Janicki S; Schleiss MB; Jörres RA; Magnussen H
Eur Respir J; 2002 Nov; 20(5):1080-7. PubMed ID: 12449158
[TBL] [Abstract][Full Text] [Related]
5. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
6. Traditional and patient-centred outcomes with three classes of asthma medication.
Jenkins CR; Thien FC; Wheatley JR; Reddel HK
Eur Respir J; 2005 Jul; 26(1):36-44. PubMed ID: 15994387
[TBL] [Abstract][Full Text] [Related]
7. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
Gelb AF; Taylor CF; Shinar CM; Gutierrez CA; Zamel N
Can Respir J; 2008; 15(4):193-8. PubMed ID: 18551200
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
10. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
O'Sullivan S; Akveld M; Burke CM; Poulter LW
Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
12. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
[TBL] [Abstract][Full Text] [Related]
14. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
15. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
[TBL] [Abstract][Full Text] [Related]
16. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures.
Verini M; Peroni DG; Piacentini GL; Nicodemo A; Rossi N; Bodini A; Chiarelli F; Boner AL
Allergy Asthma Proc; 2007; 28(6):691-4. PubMed ID: 18201433
[TBL] [Abstract][Full Text] [Related]
17. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma.
Westbroek J; Pasma HR
Respir Med; 2000 Feb; 94(2):112-8. PubMed ID: 10714415
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma.
Van Schoor J; Joos GF; Pauwels RA
Eur Respir J; 2002 Jun; 19(6):997-1002. PubMed ID: 12108885
[TBL] [Abstract][Full Text] [Related]
20. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
